Biography

Gerhard “Gary” F. Burbach is chairman of the board of directors of Procyrion Inc., a private medical device company focused on the treatment of chronic heart failure; chairman of the board of Artelon, a private biomaterial developer used for tendon and ligament reconstruction; and a director of Vascular Dynamics, Inc., a private medical device company developing innovative solutions for heart failure and hypertension. He also served on the board of directors of Fluidigm Corporation, a public company manufacturing and marketing innovative technologies for life sciences research, from 2013 to 2023.

From 2006 to 2014, Mr. Burbach was president, chief executive officer and director of Thoratec Corporation, a company that develops, manufactures and markets proprietary medical devices for circulatory support. Prior to that, he held executive leadership positions at Digirad Corporation, Philips Medical Systems, and ADAC Laboratories. Mr. Burbach also spent six years at McKinsey & Company, Inc., focused primarily on the firm’s healthcare practice.

Mr. Burbach received a bachelor’s degree in industrial engineering from Stanford University and a Master of Business Administration from Harvard Business School.